Ani intros generic Trental

Ani Pharmaceuticals is offering Pentoxifylline Extended-Release Tablets, 400 mg, which is the generic version of Trental. 

Pentoxifylline is a drug used in the management of peripheral vascular disease.

[Read more: ANI Pharmaceuticals receives ​​​​​​​FDA nod for generic Furadantin]

“We are pleased to continue the momentum in our generics business with another launch into a limited competition market. ANI remains committed to driving growth through superior new product launch execution, operational excellence, cost-competitiveness and supply reliability. With a patient-first mindset, our goal is to ensure that patients in need, and the providers who care for them, have access to our high-quality therapeutics,” said Nikhil Lalwani, president and CEO of ANI.

Pentoxifylline ER Tablets have a market value of approximately $19.7 million, per IQVIA. 

[Read more: ANI Pharmaceuticals receives ​​​​​​​FDA nod for generic Furadantin]